Comparison of Polymerase Chain Reaction–Restriction Fragment Length Polymorphism Assay and Enzyme Assay for Diagnosis of G M1 -Gangliosidosis in Shiba Dogs

Abstract

In the present study, diagnostic methods for canine G_M1-gangliosidosis were examined by comparing a DNA mutation assay with an enzyme assay. Sixty-two Shiba dogs of a pedigree with G_M1-gangliosidosis were differentiated into 3 genotypes, i.e., normal, heterozygous, and homozygous affected dogs, using a DNA mutation assay, which consists of polymerase chain reaction amplification and the determination of restriction fragment length polymorphisms. The β-galactosidase activity in leukocytes, umbilical cords, and plasma was measured using 4-methylumbelliferyl β-D-galactoside and p-nitrophenyl β-D-galactoside as artificial substrates and compared among the 3 genotypes. The results showed that it was possible to identify homozygous dogs with the enzyme assay using leukocytes and umbilical cords. When using leukocytes, heterozygous carriers could be differentiated from normal dogs in many cases. However, the use of the DNA mutation assay is essential for a complete determination of heterozygous carriers because of the overlap in the distribution of enzyme activity between these 2 groups. When umbilical cords were used, heterozygous carriers could not be differentiated from normal dogs because of no significant difference in enzyme activity between these 2 groups. The β-galactosidase activity in plasma was not applicable to the diagnosis and genotyping of G_M1-gangliosidosis in Shiba dogs.

References

Ahern-Rindell

Kretz

O'Brien

: 1996, Comparison of the canine and human acid β-galactosidase gene. Am J Med Genet 63:340–345.

Bradford

: 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254.

Callahan

: 1999, Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure-function studies of lysosomal β-galactosidase and the non-lysosomal β-galactosidase-like protein. Biochim Biophys Acta 1445:85–103.

Sakuraba

Iimori

Suzuki

: 1985, Galactosialidosis: low β-galactosidase activity in serum after long-term clotting. Ann Neurol 18:261–263.

Skoog

Beck

: 1956, Studies on the fibrinogen, dextran and phytohaemagglutinin methods of isolating leukocytes. Blood 11:436–454.

Suzuki

: 1978, Enzymic diagnosis of sphingolipidoses. Methods Enzymol 50:456–488.

Suzuki

Oshima

Nanba

: 2001, β-Galactosidase deficiency (β-galactosidosis): GM1 gangliosidosis and Morquio B disease. In: The metabolic and molecular bases of inherited disease, ed. Scriver

Beaudet

Sly

Valle

, 8th ed., pp. 3775–3809. McGraw-Hill, New York.

Wang

Zeng

Shibuya

: 2000, Isolation and characterization of the normal canine β-galactosidase gene and its mutation in a dog model of GM1-gangliosidosis. J Inherit Metab Dis 23:593–606.

Warren

Alroy

: 2000, Morphological, biochemical and molecular biology approaches for the diagnosis of lysosomal storage diseases. J Vet Diagn Invest 12:483–496.

10.

Yamato

Endoh

Kobayashi

: 2002, A novel mutation in the gene for canine acid β-galactosidase that causes GM1-gangliosidosis in Shiba dogs. J Inherit Metab Dis 25:525–526.

11.

Yamato

Masuoka

Yonemura

: 2003, Clinical and clinico-pathologic characteristics of Shiba dogs with a deficiency of lysosomal acid β-galactosidase: a canine model of human GM1 gangliosidosis. J Vet Med Sci 65:213–217.

12.

Yamato

Ochiai

Masuoka

: 2000, GM1 gangliosidosis in shiba dogs. Vet Rec 146:493–496.

13.

Yamato

Satoh

Matsuki

: 2004, Laboratory diagnosis of canine GM2-gangliosidosis using blood and cerebrospinal fluid. J Vet Diagn Invest 16:39–44.